U.S.-listed shares of GSK are gaining in intraday trading Wednesday after the British pharma giant posted ...

Going forward, PTS and Appspace are providing ongoing service and support, with a team ensuring the systems perform at peak ...

GSK and Pfizer said in the filing that they would dismiss the case with prejudice, which means it cannot be refiled. Spokespeople for the companies did not immediately respond to requests for ...

GSK has secured the first regulatory approval for Blenrep since the antibody-drug conjugate’s global market withdrawal in 2022. The U.K.’s Medicines and Healthcare products Regulatory Agency ...

GSK PLC closed 21.47% short of its 52-week high of £18.24, which the company reached on May 16th.

British pharmaceutical giant GSK has not met required ethical and regulatory standards in its marketing and prescription ...

And GSK’s first-to-market Arexvy lived up to that expectation with $1.5 billion sales in its first year of commercialization. Related As RSV vaccine clash kicks off, GSK sues Pfizer for patent ...

Deutsche Bank analyst Emmanuel Papadakis maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £14.50. The company’s shares opened today at p1 ...

GSK (GSK) plc announced the authorization of Blenrep by the Medicines and Healthcare products Regulatory Agency. “In the UK, Blenrep is approved for the treatment of adults with multiple myeloma ...

Increased activity of GSK-3β is directly associated with tau hyperphosphorylation and enhanced production, which leads to molecular dysfunctions, neuronal damage, and cognitive decline in AD.

GSK GSK and Pfizer PFE announced that the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) has recommended the expanded use of their ...